NVCR 8-K: Fda rejection
Filed with the SEC on · accession 0001645113-26-000085
NVCR filed a 8-K (current report) with the SEC on Nov 9, 2026. NovoCure received a Not Approvable Letter from the FDA for its PMA application for Optune Mya for treating adult patients with brain metastases from non-small cell lung cancer following stereotactic radiation.
Summary of the filing
NovoCure received a Not Approvable Letter from the FDA for its PMA application for Optune Mya for treating adult patients with brain metastases from non-small cell lung cancer following stereotactic radiation. The FDA cited uncertainty around the degree of clinical benefit, though no safety concerns were raised, and NovoCure plans to meet with the FDA to explore options for approval without additional clinical studies.
Key details
✦ Ask GOAX AI about this filing — what it means for NVCR, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NVCR?
Click hereFrequently asked questions
What did NVCR file with the SEC on Nov 9, 2026?
NVCR filed a 8-K (Fda rejection). NovoCure received a Not Approvable Letter from the FDA for its PMA application for Optune Mya for treating adult patients with brain metastases from non-small cell lung cancer following stereotactic radiation. The FDA cited uncertainty around the degree of clinical benefit, though no safety concerns were raised, and NovoCure plans to meet with the FDA to explore options for approval without additional clinical studies.
What does a fda rejection mean for NVCR stock?
For a small biotech one drug can be most of the company’s value. Approval opens sales; a rejection (complete response letter) can delay it by years.
How do I read a 8-K?
A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.
Other NVCR SEC filings
Get alerts when NVCR files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days